Mindpeak builds automation tools for visual diagnosis using state-of-the-art artificial intelligence and deep learning. Their tools assist cancer experts in providing reliable and reproducible diagnoses.

This technology frees specialists from tedious repetitive tasks such as quantification of cells or biomarkers, allowing them to focus on complex tasks requiring human expertise. Mindpeak emphasizes explainable AI (xAI) results which build trust with pathologists.

Founded in 2018, Mindpeak GmbH is managed by Felix Faber and registered locally in Hamburg (HRB 151143).

They have offices both in Hamburg, Germany and Cambridge, United States.

The company's products focus on bringing precision and speed to clinical pathology through AI-powered diagnostic software and integration into histology-based In Vitro Diagnostics (IVDs). Their AI tools assist in clinical diagnostics, translational research for biomarker identification, and clinical trial services for patient stratification.

Mindpeak supplies deep integration with partner software, standalone AI console access, and a wide range of automated AI solutions for pathology imaging analysis.